X4 Pharmaceuticals Correlations

XFOR Stock

USD 2.49 0.36 12.63%

The current 90-days correlation between X4 Pharmaceuticals and PDS Biotechnology Corp is 0.41 (i.e., Very weak diversification). The correlation of X4 Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

X4 Pharmaceuticals Correlation With Market

Modest diversification

The correlation between X4 Pharmaceuticals and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with XFOR Stock

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in X4 Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.

Moving together with XFOR Stock

0.71

MLYS

Mineralys Therapeutics,

Pair Corr

Moving against XFOR Stock

0.7	MGTX	MeiraGTx Holdings PLC	Pair Corr
0.68	VANI	Vivani Medical Earnings Call Today	Pair Corr
0.64	MCRB	Seres Therapeutics	Pair Corr
0.55	MEIP	MEI Pharma	Pair Corr
0.53	MBIO	Mustang Bio	Pair Corr
0.51	DNTH	Dianthus Therapeutics	Pair Corr
0.44	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.35	MESO	Mesoblast	Pair Corr
0.66	VERV	Verve Therapeutics	Pair Corr
0.5	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.39	MIRM	Mirum Pharmaceuticals	Pair Corr
0.38	SABSW	SAB Biotherapeutics	Pair Corr
0.65	OSRHW	OSR Holdings, Symbol Change	Pair Corr
0.58	MNPR	Monopar Therapeutics	Pair Corr
0.52	VIGL	Vigil Neuroscience	Pair Corr
0.52	MRNA	Moderna Aggressive Push	Pair Corr

Related Correlations Analysis

	TERN	DAWN	PDSB	INZY	ABOS	MREO	EFTR	ELEV	HEPA	HOOK
TERN		0.01	-0.75	-0.4	0.62	-0.67	0.0	0.56	-0.31	-0.65	TERN
DAWN	0.01		0.12	-0.22	0.08	0.14	0.0	-0.01	0.01	0.27	DAWN
PDSB	-0.75	0.12		0.5	-0.57	0.73	0.0	-0.57	0.34	0.63	PDSB
INZY	-0.4	-0.22	0.5		-0.51	0.41	0.0	-0.51	0.41	0.32	INZY
ABOS	0.62	0.08	-0.57	-0.51		-0.64	0.0	0.48	-0.71	-0.32	ABOS
MREO	-0.67	0.14	0.73	0.41	-0.64		0.0	-0.79	0.2	0.61	MREO
EFTR	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	EFTR
ELEV	0.56	-0.01	-0.57	-0.51	0.48	-0.79	0.0		0.03	-0.57	ELEV
HEPA	-0.31	0.01	0.34	0.41	-0.71	0.2	0.0	0.03		0.0	HEPA
HOOK	-0.65	0.27	0.63	0.32	-0.32	0.61	0.0	-0.57	0.0		HOOK
	TERN	DAWN	PDSB	INZY	ABOS	MREO	EFTR	ELEV	HEPA	HOOK

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MREO	+ 0.73	PDSB
HOOK	+ 0.63	PDSB
ABOS	+ 0.62	TERN
HOOK	+ 0.61	MREO
ELEV	+ 0.56	TERN
INZY	+ 0.5	PDSB

High negative correlations

ELEV	- 0.79	MREO
PDSB	- 0.75	TERN
HEPA	- 0.71	ABOS
MREO	- 0.67	TERN
HOOK	- 0.65	TERN
MREO	- 0.64	ABOS

Risk-Adjusted Indicators

There is a big difference between XFOR Stock performing well and X4 Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze X4 Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.41	1.21	0.34	1.11	2.76	(4.12)	7.95	(5.64)	19.99
DAWN	2.22	(0.04)	0.00	0.07	3.47	(2.49)	5.63	(4.41)	25.57
PDSB	3.56	(0.50)	0.00	(0.21)	0.00	0.00	8.33	(8.27)	19.58
INZY	0.16	0.03	0.00	0.59	0.00	0.00	0.50	(0.25)	1.01
ABOS	3.68	0.57	0.11	0.57	4.35	(4.26)	7.69	(7.09)	24.23
MREO	3.43	(0.32)	0.00	(0.20)	0.00	0.00	6.83	(5.00)	61.12
EFTR	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ELEV	3.37	0.29	0.04	2.75	3.35	(6.16)	9.09	(6.67)	29.95
HEPA	8.69	(5.36)	0.00	2.09	0.00	0.00	13.95	(25.00)	78.13
HOOK	2.68	(1.26)	0.00	(4.68)	0.00	0.00	4.76	(8.77)	18.07

X4 Pharmaceuticals Corporate Management

Brian Bowersox	VP Controller	Profile
Renato Skerlj	Founder	Profile
Arthur Taveras	Chief Officer	Profile
Murray MD	Interim Director	Profile
Mark MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC